A1 and A(2A) adenosine receptors and A1 mRNA in mouse brain: Effect of long-term caffeine treatment

Brain Research

Volumn 762, Issue 1-2, 1997, Pages 153-164

  Johansson, Björn ^a   Georgiev, Vasil ^a   Lindström, Karin ^a   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autoradiography; Cerebellum; Cerebral cortex; Hippocampus; In situ hybridization; Radioligand assay; Striatum; Tolerance

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; CAFFEINE; CYCLOHEXYLADENOSINE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ADENOSINE; ADENOSINE RECEPTOR; ANTIHYPERTENSIVE AGENT; CENTRAL STIMULANT AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MESSENGER RNA; N(6) CYCLOHEXYLADENOSINE; N(6)-CYCLOHEXYLADENOSINE; PHENETHYLAMINE DERIVATIVE; TRITIUM; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CEREBELLUM CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DIETARY INTAKE; HIPPOCAMPUS; IN SITU HYBRIDIZATION; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; ANIMAL; BRAIN LEVEL; CEREBELLUM; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; MOUSE STRAIN; RADIOASSAY; TIME;

ADENOSINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBELLUM; CEREBRAL CORTEX; CORPUS STRIATUM; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED STRAINS; PHENETHYLAMINES; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; TIME FACTORS; TRITIUM; XANTHINES;

EID: 0030611345     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00378-8     Document Type: Article

References (51)

1. Ahlijanian M.K., Takemori A.E. Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl) adenosine (PIA) in mice. Life Sci. 38:1986;577-588.
2. Alexander S.P., Reddington M. The cellular localization of adenosine receptors in rat striatum. Neuroscience. 28:1989;645-651.
3. M.J. Arnaud, Metabolism of caffeine and other components of coffee, in: S. Garattini (Ed.), Caffeine, Coffee and Health, Raven, New York, NY, 1993, pp. 43-95.
4. Bona E., Ådén U., Fredholm B.B., Hagberg H. The effect of long term caffeine treatment on hypoxic-ischemic brain damage in the neonate. Pediat. Res. 38:1995;312-318.
5. Carney J.M. Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats. Br. J. Pharmacol. 75:1982;451-454.
6. Dunwiddie T.V. The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27:1985;63-139.
7. 1-receptors in rat brain: autoradiographic evidence for increased receptor number and altered coupling to G-proteins. Brain Res. 507:1990;195-199.
8. 1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience. 22:1987;813-826.
9. Fredholm B.B. Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol. Sci. 1:1980;129-132.
10. Fredholm B.B. Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol. Scand. 115:1982;283-286.
11. Fredholm B.B. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76:1995;93-101.
12. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
13. Fredholm B.B., Dunwiddie T.V. How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9:1988;130-134.
14. Fredholm B.B., Jonzon B., Lindgren E. Changes in noradrenaline release and in beta receptor number in rat hippocampus following long-term treatment with theophylline or L-phenylisopropyladenosine. Acta Physiol. Scand. 122:1984;55-59.
15. Freissmuth M., Schütz W., Linder M.E. Interactions of the bovine brain A1-adenosine receptor with recombinant G protein alpha-subunits. Selectivity for rGi alpha-3. J. Biol. Chem. 266:1991;17778-17783.
16. 1 receptor number. Brain Res. 612:1993;271-277.
17. Gerfen C.R., McGinty J.F., Young W.S. Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
18. 3H]-cyclohexyladenosine. J. Neurosci. 2:1982;1230-1241.
19. 2 dopamine receptor protein independently of RNA levels in mice. Life Sci. 48:1991;1015-1022.
20. Green R.M., Stiles G.L. Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. J. Clin. Invest. 77:1986;222-227.
21. Hawkins M., Dugich M.M., Porter N.M., Urbancic M., Radulovacki M. Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain. Brain Res. Bull. 21:1988;479-482.
22. Holtzman S.G. Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine. Life Sci. 33:1983;779-787.
23. Holtzman S.G., Finn I.B. Tolerance to behavioral effects of caffeine in rats. Pharmacol. Biochem. Behav. 29:1988;411-418.
24. Holtzman S.G., Mante S., Minneman K.P. Role of adenosine receptors in caffeine tolerance. J. Pharmacol. Exp. Ther. 256:1991;62-68.
25. 3H]CGS 21680. Eur. J. Pharmacol. 168:1989;243-246.
26. 2 adenosine receptor binding and on mRNA levels. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;407-414.
27. Johansson B., Georgiev V., Kuosmanen T., Fredholm B.B. Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding. Eur. J. Neurosci. 8:1996;2447-2458.
28. Kaplan G.B., Greenblatt D.J., Kent M.A., Cotreau-Bibbo M.M. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. J. Pharmacol. Exp. Ther. 266:1993;1563-1572.
29. Lupica C.R., Berman R.F., Jarvis M.F. Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic study. Synapse. 9:1991;95-102.
30. 1 receptor binding and sensitivity to exogenous adenosine in the in vitro hippocampal slice. Brain Res. 542:1991;55-62.
31. 1 adenosine receptor from rat brain. Mol. Pharmacol. 40:1991;1-7.
32. 2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience. 42:1991;697-706.
33. Munshi R., Pang I.-H., Sternweis P.C., Linden J. A1 adenosine receptors of bovine brain couple to guanine nucleotide-binding proteins Gi1, Gi2 and Go. J. Biol. Chem. 266:1991;22285-22289.
34. Murray T.F. Up-regulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur. J. Pharmacol. 82:1982;113-114.
35. Nikodijeviç O., Jacobson K.A., Daly J.W. Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol. Biochem. Behav. 44:1993;199-216.
36. 1 receptors in the rat hippocampus: quantitative autoradiographic study. Brain Res. 458:1988;212-217.
37. 3H]-CGS 21680 as a ligand. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;85-89.
38. 1 receptors: a complicating factor in quantitative autoradiography. J. Neurochem. 58:1992;941-950.
39. 2 receptors: a quantitative autoradiographical study. Mol. Neuropharmacol. 1:1992;179-186.
40. 2A receptors and nitrobenzylthioinosine-sensitive transporters in gerbil brain: no changes following long-term treatment with the adenosine transport inhibitor propentofylline. Neuropharmacology. 35:1996;79-89.
41. G. Paxinos, W. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, London, UK, 1986.
42. 1 MF-2 cells. Mol. Pharmacol. 40:1991;639-647.
43. Robertson D., Wade D., Workman R., Woosley R.L., Oates J.A. Tolerance to the humoral and hemodynamic effects of caffeine in man. J. Clin. Invest. 67:1981;1111-1117.
44. 1 dopamine receptor. Brain Res. 519:1990;333-337.
45. Shi D., Nikodijevic O., Jacobson K.A., Daly J.W. Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain. Cell. Mol. Neurobiol. 13:1993;247-261.
46. Shi D., Nikodijevic O., Jacobson K.A., Daly J.W. Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice. Arch. Int. Pharmacodyn. Ther. 328:1994;261-287.
47. Snyder S.H. Adenosine as a neuromodulator. Annu. Rev. Neurosci. 8:1985;103-124.
48. 1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding. Biochem. J. 275:1991;651-656.
49. 2 dopamine receptor level. Neurosci. Lett. 111:1990;303-308.
50. 1 receptor agonist or antagonist in cerebral ischemia. Eur. J. Pharmacol. 256:1994;161-167.
51. 1 adenosine receptors in mouse cerebellar and cortical membranes. Biochem. Pharmacol. 36:1987;2533-2538.